-5%
Lino 5 contains Linagliptin, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors Linagliptin is prescribed for the condition of type 2 diabetes when diet and exercise alone cannot control blood sugar levels.Â
Linagliptin is a medication primarily used to treat type 2 diabetes in adults, often in combination with other drugs and lifestyle changes. It belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. This medication helps lower blood sugar levels by blocking the action of DPP-4, an enzyme that breaks down incretin hormones, which stimulate insulin release and reduce liver glucose production.
Lino 5. contains Linagliptin and is used for managing type 2 diabetes in adults when one oral anti-diabetic medicine or diet and exercise alone are insufficient. It may be used in combination with other anti-diabetic medications like metformin, sulphonylureas, empagliflozin, or insulin. Regular exercise and a proper diet are essential for better glucose control while taking this medication.
Type 2 diabetes is a chronic condition characterized by inadequate insulin production or insulin resistance, leading to elevated blood glucose levels and potential complications such as heart disease, kidney disease, and blindness. Symptoms include excessive urination, thirst, hunger, fatigue, and blurred vision.
Before taking Linagliptin, inform your doctor about any pancreas, heart, or kidney problems, type 1 diabetes, gallstones, or history of alcoholism. It’s generally not recommended for pregnant or breastfeeding women, and caution is advised in patients with severe kidney or liver disease.
It’s important not to stop Linagliptin abruptly without consulting your doctor, even if you feel better, as fluctuations in blood sugar levels can occur. Abrupt discontinuation may increase the risk of complications such as retinopathy, nephropathy, and neuropathy. Inform your doctor about any heart disease, pregnancy plans, or breastfeeding intentions.